1. Home/
  2. Compounds/
  3. tanespimycin:bortezomib (250:1 mol/mol)

tanespimycin:bortezomib (250:1 mol/mol)

Synonyms

SourcesNames Used
CTRPv2tanespimycin:bortezomib (250:1 mol/mol)
PharmacoGx tanespimycin:bortezomib (250:1 mol/mol)

Cell lines tested with tanespimycin:bortezomib (250:1 mol/mol)

797 cell lines have been tested with this compound, using data from 1 dataset(s).
A549 lung CTRPv23
DU-145 prostate CTRPv22
AsPC-1 pancreas CTRPv22
NCI-H1869 lung CTRPv22
CCF-STTG1 central nervous system CTRPv22
OAW-28 ovary CTRPv22
HeLa cervix CTRPv22
LOXIMVI haematopoietic and lymphoid tissue CTRPv22
NCI-H520 lung CTRPv22
IGROV-1 ovary CTRPv22
Download CSV

Tissues tested with tanespimycin:bortezomib (250:1 mol/mol)

25 tissues have been tested with this compound, using data from 1 dataset(s).
lungCTRPv2142
haematopoietic and lymphoid tissueCTRPv2135
N/ACTRPv247
central nervous systemCTRPv245
skinCTRPv244
pancreasCTRPv240
large intestineCTRPv239
ovaryCTRPv238
breastCTRPv237
stomachCTRPv232
Download CSV
Download Data as CSV

Top molecular features associated with response to tanespimycin:bortezomib (250:1 mol/mol)


Feature TypeStandardized
Nominal ANOVA
mRNA KMT5A CTRPv2 AAC 4.8e-05 1
mRNA ARHGAP18 CTRPv2 AAC -4.6e-05 1
mRNA FBXL19 CTRPv2 AAC -4.4e-05 1
mRNA MST1 CTRPv2 AAC -4e-05 1
mRNA FGF6 CTRPv2 AAC -3.8e-05 1
mRNA FNDC9 CTRPv2 AAC 4.1e-05 1
mRNA SPTBN2 CTRPv2 AAC -3.5e-05 1
mRNA KRTAP19-6 CTRPv2 AAC 3.2e-05 1
mRNA OR10V1 CTRPv2 AAC 2.8e-05 1
mRNA HAO2 CTRPv2 AAC 2.6e-05 1
Download CSV